Saniona Files FDA IND for SAN2465 in Major Depressive Disorder
Saniona submitted an IND to the FDA for SAN2465. A Phase 1 study in healthy volunteers is expected to begin by the end of 2026, contingent on FDA clearance.
Saniona submitted an IND to the FDA for SAN2465. A Phase 1 study in healthy volunteers is expected to begin by the end of 2026, contingent on FDA clearance.